GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jerusalem Pharmaceutical Co (XPAE:JPH) » Definitions » 5-Year Yield-on-Cost %

Jerusalem Pharmaceutical Co (XPAE:JPH) 5-Year Yield-on-Cost % : 2.68 (As of Apr. 29, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Jerusalem Pharmaceutical Co 5-Year Yield-on-Cost %?

Jerusalem Pharmaceutical Co's yield on cost for the quarter that ended in Dec. 2024 was 2.68.


The historical rank and industry rank for Jerusalem Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

XPAE:JPH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.46   Med: 3.31   Max: 5.1
Current: 2.68


During the past 13 years, Jerusalem Pharmaceutical Co's highest Yield on Cost was 5.10. The lowest was 2.46. And the median was 3.31.


XPAE:JPH's 5-Year Yield-on-Cost % is ranked better than
54.39% of 513 companies
in the Drug Manufacturers industry
Industry Median: 2.31 vs XPAE:JPH: 2.68

Competitive Comparison of Jerusalem Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Jerusalem Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jerusalem Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jerusalem Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Jerusalem Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.


;
;

Jerusalem Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Jerusalem Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Jerusalem Pharmaceutical Co  (XPAE:JPH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Jerusalem Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Jerusalem Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jerusalem Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.

Jerusalem Pharmaceutical Co Headlines

No Headlines